These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2146083)

  • 1. The measurement of intrarenal plasma flow distribution in essential hypertension. The effect of angiotensin-converting enzyme inhibition.
    Britton KE; al-Nahhas AM; Nimmon CC; Carroll MJ; Fiore F; Solanki K; Bomanji J
    Contrib Nephrol; 1990; 79():186-9. PubMed ID: 2146083
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of ramipril, a new angiotensin-converting enzyme inhibitor on cortical nephron flow and effective renal plasma flow in patients with essential hypertension.
    al-Nahhas AM; Nimmon CC; Britton KE; Carroll MJ; al-Janabi MA; Solanki K; Bomanji J
    Nephron; 1990; 54(1):47-52. PubMed ID: 2136939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salt blocks the renal benefits of ramipril in diabetic hypertensive rats.
    Fabris B; Jackson B; Johnston CI
    Hypertension; 1991 Apr; 17(4):497-503. PubMed ID: 1826492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of ramipril on blood pressure, ACE-activity, sperm density and motility of spontaneously hypertensive rats during puberty.
    Hilse H; Siems WE; Heder G; Stahl F; Jentzsch KD
    Pharmazie; 1991 May; 46(5):360-1. PubMed ID: 1832776
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dissociation of hypotensive and renal hemodynamic effects of an angiotensin converting enzyme inhibitor in insulin-dependent diabetic patients with incipient nephropathy].
    Hallab M; Billiard A; Lejeune JJ; Bled F; Girault A; Fressinaud P; Marre M
    Arch Mal Coeur Vaiss; 1991 Mar; 84(3):383-6. PubMed ID: 1828659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired renal haemodynamic response to amino acid infusion in essential hypertension during angiotensin converting enzyme inhibitor treatment.
    Tietze IN; Sørensen SS; Ivarsen PR; Nielsen CB; Pedersen EB
    J Hypertens; 1997 May; 15(5):551-60. PubMed ID: 9170009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an angiotensin-converting enzyme inhibitor on blood pressure and erythropoiesis in rats.
    Gould AB; Goodman SA
    Eur J Pharmacol; 1990 Jun; 181(3):225-34. PubMed ID: 2143478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on autonomic function of a new angiotensin converting enzyme inhibitor, ramipril.
    Sugimoto K; Kumagai Y; Tateishi T; Seguchi H; Ebihara A
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S40-4. PubMed ID: 2474100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic effects of a single 10-mg dose of the angiotensin converting enzyme inhibitor ramipril in patients with impaired renal function.
    Ocón-Pujadas J; Debusmann ER; Jane F; Lahn W; Irmisch R; Mora J; Grötsch H
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S45-8. PubMed ID: 2474101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of converting enzyme inhibitors on cardiac changes in experimental uremia.
    Rambausek M; Mall G; Kollmar S; Ritz E
    Kidney Int Suppl; 1988 Sep; 25():S201-3. PubMed ID: 2972864
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats.
    Linz W; Henning R; Schölkens BA
    J Hypertens Suppl; 1991 Dec; 9(6):S400-1. PubMed ID: 1840203
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of ramipril, a new angiotensin converting enzyme inhibitor, on diurnal variations of blood pressure in essential hypertension.
    Kaneko Y; Omae T; Yoshinaga K; Iimura O; Inagaki Y; Ishii M; Saruta T; Yamada K; Kumahara Y; Ito K
    Am J Cardiol; 1987 Apr; 59(10):86D-91D. PubMed ID: 3034040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, converting enzyme inhibition and peripheral arterial hemodynamics of ramipril in healthy volunteers.
    Thuillez C; Richer C; Giudicelli JF
    Am J Cardiol; 1987 Apr; 59(10):38D-44D. PubMed ID: 3034032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure response of nephrectomized subjects and patients with essential hypertension to ramipril: indirect evidence that inhibition of tissue angiotensin converting enzyme is important.
    Wenting GJ; Blankestijn PJ; Poldermans D; van Geelen J; Derkx FH; Man in't Veld AJ; Schalekamp MA
    Am J Cardiol; 1987 Apr; 59(10):92D-97D. PubMed ID: 3034041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the antihypertensive effect of single doses of the angiotensin converting enzyme inhibitor ramipril (HOE 498) in man.
    Böhm RO; van Baak MA; Rahn KH
    Eur J Clin Pharmacol; 1986; 30(5):541-7. PubMed ID: 3019702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of ramipril diacid on the peripheral vascular effects of angiotensin I.
    Webb DJ; Collier JG
    Am J Cardiol; 1987 Apr; 59(10):45D-49D. PubMed ID: 2953225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term effects of ramipril in hypertension.
    de Leeuw PW; Birkenhäger WH
    Am J Cardiol; 1987 Apr; 59(10):79D-82D. PubMed ID: 3034038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global and regional hemodynamic effects of ramipril in congestive heart failure.
    Crozier IG; Ikram H; Nicholls MG; Jans S
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):688-93. PubMed ID: 2481181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin-converting enzyme inhibition on human tissue renin.
    Rosenthal J; Buehler G; Koenig W; Rangoonwala B
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S122-4. PubMed ID: 1725019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.